LBPH - Longboard Pharmaceuticals GAAP EPS of -$0.65 misses by $0.04
2023-08-04 09:28:25 ET
- Longboard Pharmaceuticals press release ( NASDAQ: LBPH ): Q2 GAAP EPS of -$0.65 misses by $0.04 .
- At June 30, 2023, Longboard’s cash, cash equivalents and short-term investments were approximately $63.0 million.
For further details see:
Longboard Pharmaceuticals GAAP EPS of -$0.65 misses by $0.04